Research and development company leveraging biology of emerging research organisms

Developer of a drug engineering platform intended to help pharmaceutical companies automate drug discovery. The company employs deep learning and quantum machine learning to identify protein interaction sites and find the exact chemical compounds to create the right drugs and treatments for a range of medical conditions, thus helping pharmaceutical companies to find a drug…

The Next Advancement in Gene Therapy

Developer of immuno-oncolody therapeutics designed to develop biologics to treat cancer. The company’s therapeutics mainly focus on engineering next generation immunotherapies to treat cancer, addressing many of the limitations associated with current therapies, enabling patients to have access to better form of cancer treatment.

ActiveSite Pharmaceuticals utilizes proprietary lead discovery technology to discover new small molecule drug candidates for human diseases with unmet medical need. Our initial efforts are focused on developing novel, innovative treatments for the major vision-threatening complication of diabetes, diabetic macular edema, and the genetic disease hereditary angioedema, by targeting the vascular protease plasma kallikrein.

Developer of gene technologies designed to improve the efficiency and enhance the safety of CRISPR-Cas-based gene editing. The company’s technologies offer Acr proteins to control the CRISPR-Cas gene editing process to create an improved CRISPR gene, enabling companies to have an editing platform for safe and effective gene therapies.

i3 Nanotec is involved in the development of membrane-based, energy efficient, and environmentally friendly processes for a wide range of industrial applications. Among the industries that i3 Nanotec is actively working in are chemical, pharmaceutical, API & intermediates, food and beverage, fuel grade ethanol, fuel cells, electronics, petrochemicals, refining, and natural gas.

Gritstone Oncology is developing next-generation personalized immunotherapies to fight cancer in patients with the most difficult-to-treat tumors.